𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Inflammation and hepatic encephalopathy: Ibuprofen restores learning ability in rats with portacaval shunts

✍ Scribed by Omar Cauli; Regina Rodrigo; Blanca Piedrafita; Jordi Boix; Vicente Felipo


Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
199 KB
Volume
46
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

✦ Synopsis


One of the neurological alterations in patients with minimal or overt hepatic encephalopathy is cognitive impairment. This impairment is reproduced in rats with chronic liver failure due to portacaval shunt (PCS). These rats show decreased ability to learn a conditional discrimination task in a Y-maze, likely due to reduced function of the glutamate-nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) pathway in brain. It has been proposed that inflammation exacerbates the neuropsychological alterations induced by hyperammonemia, suggesting that inflammation-associated alterations may contribute to cognitive impairment in hepatic encephalopathy. This study assessed whether treatment with an anti-inflammatory drug, ibuprofen, is able to restore the function of the glutamate-NO-cGMP pathway in cerebral cortex in brain in vivo and/or learning ability in PCS rats. We show that PCS rats have increased levels of interleukin-6 and increased activities of cyclooxygenase and of inducible NO synthase in cerebral cortex, indicating the presence of inflammation. Chronic treatment with ibuprofen normalizes cyclooxygenase and inducible NO synthase activities but not interleukin-6 levels. Moreover, ibuprofen normalizes the function of the glutamate-NO-cGMP pathway in cerebral cortex in vivo and completely restores the ability of rats with chronic liver failure to learn the Y-maze task. This supports that inflammation contributes to the cognitive impairment in hepatic encephalopathy.

Conclusion:

The results reported point to the possible therapeutic utility of decreasing inflammation in the treatment of the cognitive deficits in patients with minimal or overt hepatic encephalopathy.


πŸ“œ SIMILAR VOLUMES


Oral administration of sildenafil restor
✍ Slaven Erceg; Pilar Monfort; Mariluz HernΓ‘ndez-Viadel; Regina Rodrigo; Carmina M πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 189 KB

Patients with liver disease with overt or minimal hepatic encephalopathy show impaired intellectual capacity. The underlying molecular mechanism remains unknown. Rats with portacaval anastomosis or with hyperammonemia without liver failure also show impaired learning ability and impaired function of

Neuroinflammation contributes to hypokin
✍ Omar Cauli; Regina Rodrigo; Blanca Piedrafita; Marta Llansola; Mohammad T. Manso πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 196 KB

## Abstract Patients with hepatic encephalopathy show altered motor function, psychomotor slowing, and hypokinesia, which are reproduced in rats with portacaval shunts (PCS). Increased extracellular glutamate in substantia nigra pars reticulata (SNr) is responsible for hypokinesia in PCS rats. The